10 minutes read

Most international patients arriving in China for medical care eventually realize the first real question wasn’t “which doctor?” — it was “which city?” China is large, its hospital clusters are spread across very different cities, and the gap between cities in specialty depth, English service, and airport access is wider than most expect. This guide breaks down the four destinations that actually matter for international patients — Beijing, Shanghai, Guangzhou, and Hangzhou — plus two special-case notes (Shenzhen as a Hong Kong entry point, and Hainan Boao as a special-import-drug pathway), so you can settle the “where” before booking flights.

Why These Four Cities

China has over 11,000 hospitals nationwide [1], but only a handful of cities combine the three things international patients actually need: a real international airport, smooth visa logistics, and a complete hospital cluster. The Fudan University Hospital Rankings — the most respected hospital ranking system in China, published annually by the Fudan University Institute of Hospital Management [2] — show that Beijing and Shanghai together hold nearly half of the top 100 hospitals nationwide, while Guangzhou and Hangzhou anchor southern and eastern China respectively.

These four cities cover the vast majority of international patient cases. Other cities (Chengdu, Wuhan, Xi’an, Tianjin) have strong specialty centers but less mature international service infrastructure, so they’re outside the scope of this article.

Beijing · The Deepest Specialty Bench

Strong in: Cardiovascular, neurosurgery, orthopedics, oncology, general internal medicine.

Anchor hospitals:

  • Peking Union Medical College Hospital (PUMC) — the benchmark for general medicine in China, ranked #1 overall on the Fudan Rankings for 15 consecutive years [2]
  • Fuwai Hospital — National Center for Cardiovascular Diseases [3]
  • Tiantan Hospital — National Center for Neurological Disorders [4]
  • Jishuitan Hospital — National Center for Orthopedics [5]
  • Cancer Hospital, Chinese Academy of Medical Sciences — National Cancer Center [6]
  • PLA General Hospital (301) — leading tertiary academic medical center

International services: Beijing’s municipal government reported in 2025 that the city operates 52 International Medical Departments, 156 hospitals offering full-process foreign-language services, and 167 medical institutions accepting foreign-card payment [7]. PUMC, 301, Fuwai, and Anzhen all maintain dedicated International Medical Departments.

Price level: The highest tier in China. Comparable procedures run 10–20% more than in Guangzhou or Hangzhou.

Airports: Beijing Capital (PEK) and Daxing (PKX) — together the densest concentration of European and North American direct flights in mainland China.

Best suited to:

  • Complex, rare, or cross-specialty cases
  • Specialty-defining procedures in cardiac, neuro, oncology, and orthopedics
  • Patients who specifically want to consult at “the center of Chinese medicine” for diagnostic confirmation or treatment decisions

Shanghai · Broadest Coverage, Most Developed Private International Sector

Strong in: Oncology, hepatobiliary, cardiovascular, pediatrics, reproductive medicine, gastroenterology, endocrinology.

Anchor hospitals:

  • Ruijin Hospital — leading in hematology, endocrinology, and burn care; consistently top-five on Fudan Rankings [2]
  • Huashan Hospital — top-tier neurology, dermatology, and hand surgery [2]
  • Zhongshan Hospital — top-three overall nationally, particularly renowned for hepatobiliary surgery [2]
  • Fudan University Cancer Hospital — largest oncology specialty center in eastern China [8]
  • Xinhua Hospital / Renji Hospital (Shanghai Jiao Tong University) — pediatrics and organ transplant
  • Eastern Hepatobiliary Surgery Hospital — leading center for liver cancer surgery

Private international hospital cluster: Shanghai has the densest concentration of private international hospitals in China. Jiahui International Hospital [9], United Family Shanghai [10], and ParkwayHealth all operate full inpatient capability. International patients can complete the full diagnostic-to-treatment journey within Shanghai’s private system without needing to transfer to the public sector — unusual in China.

International services: Shanghai has long pursued its “Asian medical center city” strategy, and now operates dozens of medical institutions equipped for foreign patient services [11].

Price level: Comparable to Beijing. Private hospital pricing may be slightly higher than Beijing equivalents.

Airports: Pudong International (PVG) and Hongqiao (SHA). PVG is mainland China’s second-largest international hub and offers the densest European and North American direct-flight network.

Best suited to:

  • Oncology patients, particularly liver, gastrointestinal, and lung cancer
  • Patients wanting the full “private hospital + complete English + international insurance direct billing” experience
  • Premium executive checkups, assisted reproduction, complex pediatric cases
  • Patients flying direct from Europe or North America

Guangzhou · The Value Choice — Plus Integrative TCM, Nasopharyngeal Cancer, and Ophthalmology

Strong in: Nasopharyngeal cancer and head & neck oncology, ophthalmology, respiratory medicine, traditional Chinese medicine (TCM) and integrative medicine, cardiovascular, dentistry.

Anchor hospitals:

  • Sun Yat-sen University Cancer Center (SYSUCC) — National Clinical Medical Research Center for Malignant Tumors. SYSUCC’s nasopharyngeal cancer research output has appeared consistently in The Lancet, JAMA Oncology, and the Journal of Clinical Oncology, placing it in the top global tier for this specialty [12]
  • The First Affiliated Hospital, Sun Yat-sen University — strongest comprehensive hospital in southern China
  • Zhongshan Ophthalmic Center — National Center for Ophthalmology, ranked #1 in ophthalmology on the Fudan Rankings [2]
  • The First Affiliated Hospital, Guangzhou Medical University — National Center for Respiratory Medicine, home to the team led by Dr. Zhong Nanshan [13]
  • Guangdong Provincial Hospital of Chinese Medicine — one of China’s largest and most recognized TCM hospitals, consistently ranked in the top three for TCM on the Fudan Rankings alongside Beijing’s Xiyuan and Guang’anmen hospitals [2]
  • Nanfang Hospital — tertiary academic hospital with multiple leading specialties
  • United Family Guangzhou — the only United Family comprehensive inpatient hospital in southern China [10]

Guangzhou’s underrated edge: Integrative TCM and Western medicine. Guangdong Provincial Hospital of Chinese Medicine has long held the highest annual outpatient volume of any TCM hospital in China [14]. For international patients open to integrative protocols — acupuncture, herbal medicine to manage chemotherapy side effects, chronic disease modulation — Guangzhou offers the most complete environment in the country. Beijing’s Xiyuan and Guang’anmen are also top-tier, but Guangzhou’s integration of leading TCM with top-tier Western tertiary hospitals (First Affiliated, SYSUCC, Nanfang) is more seamless.

International services: Guangzhou received National Development and Reform Commission approval as an international medical pilot city in 2024, and operates the Nansha International Medical Service Pilot Zone [15]. United Family Guangzhou and the International Medical Department at Guangdong Provincial People’s Hospital are the main entry points for international patients.

Price level: Typically 10–20% lower than Beijing or Shanghai. Some private hospitals price at Beijing levels.

Airports: Baiyun International (CAN). Direct routes to Europe and North America include London (Heathrow and Gatwick), Paris CDG, Amsterdam, Frankfurt, Madrid, Los Angeles, New York JFK, Vancouver, and Toronto [16]. Frequency is lower than Shanghai Pudong but transit is not required. From Southeast Asia and the Middle East, CAN offers the densest direct-flight network in mainland China.

Best suited to:

  • Nasopharyngeal cancer, head & neck cancers, respiratory disease
  • Ophthalmology, including pediatric ophthalmology
  • Patients seeking integrative TCM + Western medicine protocols — Guangzhou’s unique strength
  • Patients flying from Southeast Asia, the Middle East, Hong Kong, or Macau
  • Patients wanting full English + insurance direct billing but at prices below Beijing/Shanghai (United Family Guangzhou’s positioning)

Hangzhou · The Frontier for Hematology and CAR-T Cell Therapy

Strong in: Hematology, CAR-T and cell therapy, organ transplant, gastroenterology, precision oncology.

Anchor hospitals:

  • The First Affiliated Hospital, Zhejiang University School of Medicine — leading hematology and bone marrow transplant center. The team led by Dr. Huang He has international visibility in CAR-T research, publishing as corresponding author in Nature in 2022 on non-viral specifically-targeted CAR-T therapy for B-cell non-Hodgkin lymphoma [17], and in the New England Journal of Medicine in 2024 on sequential CD7 CAR-T therapy combined with allogeneic HSCT without GVHD prophylaxis [18]
  • The Second Affiliated Hospital, Zhejiang University School of Medicine — strong in ophthalmology and neurosurgery
  • Zhejiang Cancer Hospital — specialty oncology center

On CAR-T therapy: As of 2025, six CAR-T cell therapy products are approved by the National Medical Products Administration (NMPA) in China — Fosun Kite’s Yikaida, JW Therapeutics’ Carteyva, Legend Biotech’s cilta-cel, Hervor Biotech’s naxitamab, Innovent/Bredon’s fuca-cel, and CARsgen’s zeva-cel [19] — covering CD19-positive hematologic malignancies and BCMA-positive multiple myeloma. Centers actively delivering CAR-T treatment beyond Hangzhou include Peking University People’s Hospital, Institute of Hematology, CAMS (Tianjin), Shanghai Ruijin Hospital, and Xuzhou Medical University Affiliated Hospital [19].

International services: The First Affiliated Hospital of Zhejiang University does not maintain a fully developed English-language international patient portal. This matters: clinical capability is excellent, but the international service infrastructure is less mature than in Beijing or Shanghai. International patients pursuing CAR-T treatment in Hangzhou typically need a medical coordination partner to handle translation and logistics — it’s not as turn-key as the private international hospitals in Shanghai.

Price level: Slightly lower than Beijing or Shanghai. Because CAR-T itself is a high-cost treatment (domestically approved CAR-T pricing runs approximately RMB 1.0–1.3 million per treatment) [19], the city-level price differential is small relative to the procedure cost. Notably, this is roughly one-third the cost of comparable CAR-T therapy in the United States.

Airports: Hangzhou Xiaoshan International (HGH) — strong Asian network, limited European and North American direct flights. Most international patients connect through Shanghai Pudong (PVG) or Beijing (PEK); PVG to Hangzhou is a 1-hour high-speed rail ride.

Best suited to:

  • Relapsed/refractory B-cell lymphoma, acute lymphoblastic leukemia, or multiple myeloma patients where CAR-T is the key option
  • Other hematologic malignancies and bone marrow transplant cases
  • Patients open to NMPA-approved Chinese CAR-T products (roughly one-third the cost of equivalent U.S. treatment)
  • Important: Patients should plan to use a medical coordination service for translation and logistics — Hangzhou is not yet a “walk in alone” destination

A Simple Decision Table

Your situation Recommended city
Complex cardiac / neuro / top-tier specialty surgery Beijing
Full English + insurance direct billing + private experience Shanghai
Nasopharyngeal cancer, respiratory, ophthalmology Guangzhou
Integrative TCM + Western medicine Guangzhou
CAR-T / hematology / bone marrow transplant Hangzhou
Liver cancer, hepatobiliary Shanghai
General oncology (other than NPC and liver) Shanghai / Beijing
Premium checkup / IVF / dental Shanghai / Guangzhou
Flying direct from Europe or North America Shanghai (PVG) first
Flying from Southeast Asia or the Middle East Guangzhou (CAN) first
Self-pay, budget-conscious Guangzhou / Hangzhou

A Note on Shenzhen: Not a Destination — It’s a Hong Kong Entry Point

Many readers ask about Shenzhen. To be direct: Shenzhen does not function as a standalone international medical destination. In 2023, Shenzhen provided medical services to 770,000 visits by non-mainland-resident patients, of which 640,000 (83%) were Hong Kong and Macau residents [20]. Shenzhen’s “international patients” are overwhelmingly Hong Kong residents traveling north for care, not international medical travelers flying in from around the world.

Two scenarios make Shenzhen worth considering:

  1. You’re based in (or entering through) Hong Kong: Hong Kong Airport (HKG) to Shenzhen’s Futian or Lo Wu border crossings is roughly one hour by cross-border coach, putting you directly in central Shenzhen. The University of Hong Kong-Shenzhen Hospital (HKU-SZH) is operated under University of Hong Kong management, using Hong Kong quality control and service standards [21]. It’s friendly to Hong Kong insurance and is the main entry point for HK residents traveling north.
  2. You want Hong Kong-style premium service for routine care: Qianhai Shekou Free Trade Zone Hospital, Shenzhen Hengsheng Hospital, and the International Medical Center at Sun Yat-sen University Seventh Affiliated Hospital are participating in Shenzhen’s international medical tourism pilot program [22]. These are appropriate for executive checkups, light cosmetic procedures, and assisted reproduction.

Shenzhen’s specialty depth for complex cases doesn’t match Guangzhou’s. Within the Greater Bay Area, Guangzhou hosts multiple national-level specialty centers (First Affiliated SYSU, SYSUCC, Nanfang, Guangdong Provincial TCM, Guangzhou Medical University First Affiliated) — Shenzhen has nothing of equivalent caliber. So if your goal is complex disease treatment, choose Guangzhou (either flying directly into CAN, or taking the high-speed rail from West Kowloon to Guangzhou South — door-to-door about 2.5–3 hours from HKG). Choose Shenzhen only if you’re already in Hong Kong and want the nearest cross-border option for routine care or Hong Kong-style premium service.

A Note on Hainan Boao: Its Core Value Isn’t “Serving Foreigners”

Hainan’s Boao Lecheng International Medical Tourism Pilot Zone operates under a unique policy: medical institutions inside the zone are licensed to use imported drugs and medical devices that have not yet received China NMPA approval (“special licensed medical care”). As of 2024, zero-tariff treatment also applies to qualifying imported drugs and devices [23]. The zone houses Boao Super Hospital, Boao Evergrande International Hospital, Ruijin Hainan Hospital (Shanghai Jiao Tong University’s Ruijin Hospital Hainan branch), and Boao Yiling Life Care Center, among approximately 27 operating institutions and 20+ more under construction [24].

But honestly: Boao Lecheng’s core value proposition is enabling Chinese mainland patients to access foreign drugs and devices, not serving foreign patients flying into China. Publicly available data does not provide reliable counts of international patient volume in the zone. If you are a mainland China resident — or being referred by family or an institution — and want access to an oncology drug or medical device that’s available abroad but not yet approved in China, Boao is worth exploring. If you’re an international patient flying in from Europe, the Middle East, or Southeast Asia, Boao is generally not the right destination — those drugs and devices are likely already available in your home country, and Boao’s English service infrastructure and international coordination capacity are significantly less developed than the established centers in Beijing, Shanghai, Guangzhou, or Hangzhou.

An Often-Overlooked Dimension: Climate and Recovery

If your treatment requires 1–4 weeks of inpatient stay plus a recovery period, city climate affects the actual experience:

  • Beijing: Dry, cold winters (lows around -10°C are normal). Autumn is best.
  • Shanghai: Rainy season in June–July (humid), summer is hot and humid. Spring and autumn are most comfortable.
  • Guangzhou: Subtropical. October to March is pleasant; April to September is hot and rainy.
  • Hangzhou: Similar to Shanghai. Spring and autumn are best.

For orthopedic or cardiovascular surgery requiring extended recovery, most international patients avoid Beijing’s winter and southern China’s rainy season.

How Real Patients Actually Choose

The overwhelming majority of international patients complete their entire treatment in a single city — initial consultation, imaging, treatment plan, surgery, and follow-up all within one hospital or one local hospital network. Multi-city travel adds cost, creates friction in transferring medical records, and complicates coordination between physicians.

So “pick the city first, then the hospital” is the correct order:

  1. Look at your core diagnosis: Hematologic malignancy → Hangzhou. Nasopharyngeal cancer → Guangzhou. Complex cardiac or neuro → Beijing. Hepatobiliary cancer → Shanghai.
  2. Look at your English dependency and insurance type: High English dependency + insurance direct billing → Shanghai private, with United Family Guangzhou as backup. Comfortable working with a medical coordinator → Beijing and Hangzhou both work.
  3. Look at your flight route: Direct from Europe or North America → PVG is most convenient. From Southeast Asia or the Middle East → CAN is most convenient. From Hong Kong → choose Guangzhou or Shenzhen based on your case type.

Common Questions

Can I change cities mid-treatment? Yes, but it’s costly. Most hospitals accept imaging and pathology results from other accredited institutions, but switching cities means rebuilding the patient-physician relationship, re-booking appointments, and coordinating logistics from scratch. Decide the city before you depart.

Which city has the easiest visa process? All four cities have similar capacity to issue M-visa (medical) supporting documents. Beijing and Shanghai’s international medical institutions produce the most standardized “treatment confirmation letters,” which tend to have the highest visa approval rates.

Can residents of Hong Kong, Macau, Taiwan, or international visitors use Chinese public health insurance? HKU-SZH accepts certain Hong Kong insurance plans. Most other public hospitals don’t accept foreign insurance. Private international hospitals primarily rely on direct billing with international commercial insurers.

Which city is most affordable? Typically Guangzhou, with Hangzhou second. Shenzhen pricing is variable. Beijing and Shanghai are the most expensive, though the gap on comparable procedures is usually 10–20%.

Bottom Line

Pick the city first, then the hospital. The city determines your flight route, visa logistics, insurance handling, accommodation, and recovery experience. Selecting the doctor from within that city’s qualified pool rarely leads to a wrong choice. Choosing the doctor first — and then realizing the city has limited direct flights or unfamiliar visa procedures — is a far more common mistake.

If you’re not sure which city fits your case, send us a brief case description. Our Free Pathway Scan returns a written recommendation within 1–2 business days.

→ Send your case to hello@medcareinchina.com

See Service & Refund Policy and Medical Disclaimer for service boundaries.

Sources

  1. Total hospitals in China — National Health Commission of the People’s Republic of China, “2023 National Health Statistical Bulletin.” http://www.nhc.gov.cn/guihuaxxs/
  2. Fudan University Hospital Rankings and Specialty Rankings — Published annually by the Fudan University Institute of Hospital Management; the most respected hospital ranking system in China. PUMC has held the #1 overall ranking for 15 consecutive years; Zhongshan Ophthalmic Center has long held #1 in ophthalmology. Most recent: 2023 annual report (published November 2024). https://rank.cn-healthcare.com/fudan/national-general
  3. Fuwai Hospital — National Center for Cardiovascular Diseases. Chinese Academy of Medical Sciences Fuwai Hospital. https://www.fuwaihospital.org/
  4. Tiantan Hospital — Beijing Tiantan Hospital, Capital Medical University. National Center for Neurological Disorders. https://www.bjtth.org/
  5. Jishuitan Hospital — Beijing Jishuitan Hospital. National Center for Orthopedics. https://www.jst-hosp.com.cn/
  6. Cancer Hospital, Chinese Academy of Medical Sciences — National Cancer Center. http://www.cicams.ac.cn/
  7. Beijing international medical services data 2025 — Beijing Municipal Government Foreign Affairs Office. https://wb.beijing.gov.cn/home/dwhz/zczx/lqjs/202507/t20250728_4160417.html
  8. Fudan University Cancer Hospital — https://www.shca.org.cn/
  9. Jiahui International Hospital (Shanghai) — https://www.jiahui.com/
  10. United Family Healthcare — Shanghai: https://shanghai.ufh.com.cn/ ; Guangzhou: https://guangzhou.ufh.com.cn/ . MedCareInChina has a written cooperation agreement with United Family Guangzhou as of 2026.
  11. Shanghai Asian medical center city initiative — Shanghai Municipal Health Commission public information. https://wsjkw.sh.gov.cn/
  12. Sun Yat-sen University Cancer Center (SYSUCC) — National Clinical Medical Research Center for Malignant Tumors. SYSUCC has continuous publication output on nasopharyngeal cancer in The Lancet, JAMA Oncology, and Journal of Clinical Oncology. https://www.sysucc.org.cn/
  13. The First Affiliated Hospital, Guangzhou Medical University / National Center for Respiratory Medicine — Institution led by Dr. Zhong Nanshan. https://www.gyfyy.com/
  14. Guangdong Provincial Hospital of Chinese Medicine — Second Affiliated Hospital of Guangzhou University of Chinese Medicine. Holds the highest annual outpatient volume of any TCM hospital in China. https://www.gdhtcm.com/
  15. Guangzhou international medical pilot designation — Approval by the National Development and Reform Commission in 2024; public information from Guangzhou Municipal Health Commission. https://wjw.gz.gov.cn/
  16. Guangzhou Baiyun Airport international routes to Europe and North America — Civil Aviation Administration of China and China Southern Airlines public information. As of 2025, CAN direct routes to Europe and North America include London Heathrow, London Gatwick, Paris CDG, Amsterdam, Frankfurt, Madrid, Los Angeles, New York JFK, Vancouver, and Toronto. http://www.caacnews.com.cn/ and https://www.csair.com/
  17. Zhejiang University First Affiliated Hospital CAR-T research in B-NHL — Huang H, et al. “Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.” Nature 609, 369–374 (2022). https://www.nature.com/articles/s41586-022-05140-y
  18. CD7 CAR-T sequential allogeneic HSCT research — Zhejiang University team, published in NEJM 2024. “Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.” https://www.nejm.org/doi/full/10.1056/NEJMoa2313812
  19. NMPA-approved CAR-T products in China — As of 2025, the NMPA has approved six CAR-T products: Fosun Kite’s Yikaida (2021, CD19), JW Therapeutics’ Carteyva (2021, CD19), Legend Biotech’s cilta-cel (2024, BCMA), Hervor Biotech’s naxitamab (CD19), Innovent/Bredon’s fuca-cel (BCMA), and CARsgen’s zeva-cel (BCMA). Clinical pricing runs approximately RMB 1.0–1.3 million per treatment. Centers actively delivering CAR-T treatment beyond Hangzhou include Peking University People’s Hospital, Institute of Hematology CAMS (Tianjin), Shanghai Ruijin Hospital, and Xuzhou Medical University Affiliated Hospital. Source compilation: https://www.21jingji.com/article/20240828/herald/43d7390550fc363ad44b1f48d4658078.html
  20. Shenzhen non-mainland-resident medical visits 2023 — Shenzhen Municipal Health Commission public data. https://wjw.sz.gov.cn/
  21. The University of Hong Kong-Shenzhen Hospital (HKU-SZH) — Operated under University of Hong Kong management, using Hong Kong quality control and service standards. https://www.hku-szh.org/
  22. Shenzhen international medical pilot hospitals 2024 — Shenzhen Municipal Health Commission. In 2024, Shenzhen announced 10 hospitals as pilots for international medical tourism. https://wjw.sz.gov.cn/
  23. Boao Lecheng special licensed medical care and zero-tariff policy — State Council and Ministry of Finance documents. Qiushi (official) policy explanation: https://www.qstheory.cn/20251012/08375f35d04e4b60869e5e1e84590a61/c.html . Ministry of Finance zero-tariff document: https://gss.mof.gov.cn/gzdt/zhengcefabu/202409/t20240905_3943199.htm
  24. Boao Lecheng zone institutional composition — Operating institutions include Boao Super Hospital, Boao Evergrande International Hospital, Ruijin Hainan Hospital (Shanghai Jiao Tong University Ruijin Hospital Hainan branch), and Boao Yiling Life Care Center. As of the latest public data, approximately 27 institutions are operating with 20+ more under construction. https://www.boaolecheng.com/